Clinical trials showed average weight loss of 5-8% of body weight with liraglutide 3.0mg daily, roughly half of what semaglutide or tirzepatide achieves
Our broken healthcare system is not a partisan issue
A large retrospective study of over 18,000 patients found that those taking tirzepatide lost approximately 15.3% of body weight in one year compared to 8.3% with semaglutide
Variable modifications included oxidation (M, +15.9949, max occurrences 3), N -terminal acetylation ([^, +42.0106, max occurrences 1), N -terminal TMT adduct (n^, +229.16293, max occurrences 1) and serine TMT adduct (S, +229.16293, max occurrences 1)
All individuals considering GLP-1 therapy must undergo comprehensive medical evaluation by licensed healthcare providers who can assess individual appropriateness based on complete medical history, current health status, medications, and personal circumstances
We provide regular follow-up appointments to monitor your progress, manage any side effects, and adjust your dosage as neededensuring you achieve the best possible results in a safe, supportive environment